Cardiovascular disease (CVD) remains the leading cause of death for women across the globe, yet significant progress has been made in prevention, diagnosis and management thanks to more sex-specific ...
Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular ...
In a recently published Journal of the American Heart Association study, of nearly 1 million post-9/11 U.S. veterans, researchers found that adults with both insomnia and obstructive sleep apnea face ...
FAYETTEVILLE, Ark., Feb. 9, 2026 /PRNewswire/ -- HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused healthcare accelerator that facilitates guaranteed ...
Cardiovascular diseases (CVDs) remain the leading cause of global mortality, necessitating a shift from traditional reactive treatments to proactive, ...
Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely ...
Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...
Clean air laws have led to a significant reduction in long-term exposure to fine particulate air pollution across much of the ...
The Association of Black Cardiologists launched a campaign to improve heart health education in “cardiovascular deserts,” underscoring results of a survey showing some Americans have low awareness ...
Top Stories from Feb. PENSACOLA, Fla. (WKRG) — Ascension Sacred Heart Pensacola is among the nation’s Top 50 cardiovascular ...
Clonal hematopoiesis (CH), the benign clonal expansion of hematopoietic stem cells, is often caused by somatic sequence variations in genes associated with hematologic malignancies. Over the past ...
In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...